About Us | Contact

Catherine Jean Chamberlain

NPI1083031199
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$150.00
from 1 payments in the last 6 years

Total Cash or Cash Equivalent

$150.00
from 1 payments in the last 6 years

Total In-kind Items & Services

$0.00
from 0 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
07/21/2020 Research Cash or cash equivalent Drug $150.00 Details
Payment from Indivior Inc.
Paymment Research Study Quantitative Testing of Prescriber/Pharmacist Knowledge, Attitudes and Behavior about SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) or the Authorized Generic of SUBOXONE Sublingual Film (CIII) Safety and Use Information
Payment Record ID 752717641
;